Products

What will AGI do for Albendazole?

This classification denotes an antihelminthic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F4216019LN. European Medicines Agency schedules Albendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05295MIG. Albendazole generally arises in the molecular formula C12H15N3O2S. The term ALBENDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16.) ALBENDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule albendazole under HS 29339990 and SITC 51577. As of Q4 2014, ALBENDAZOLE remains the US FDA Preferred Term for this commodity. Albendazole bears US NLM identifiers UMLS ID C0591462 and NCI Concept Code C47384. SMILES: CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC.

How AGI delivers it

Four ways AGI delivers for Albendazole

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Albendazole, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Albendazole, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Albendazole connects

measured by

  • Assay Contentmodel
  • Chromatographic Impurity Profilemodel
  • Compound Puritymodel
  • Loss On Dryingmodel
  • Particle Size Distributionmodel